Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity ; day:09 ; month:12 ; year:2024 ; extent:12
Angewandte Chemie ; (09.12.2024) (gesamt 12)

Creator: Lentschat, Hannah
Liessmann, Fabian
Tydings, Claiborne
Schermeng, Tina
Stichel, Jan Dirk
Urban, Nicole
Schaefer, Michael
Meiler, Jens
Beck‐Sickinger, Annette G.

DOI: 10.1002/ange.202417786

URN: urn:nbn:de:101:1-2412101319159.240912007805

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:36 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lentschat, Hannah
Liessmann, Fabian
Tydings, Claiborne
Schermeng, Tina
Stichel, Jan Dirk
Urban, Nicole
Schaefer, Michael
Meiler, Jens
Beck‐Sickinger, Annette G.

Other Objects (12)

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Hochschulschrift

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Hederagenin is a Highly Selective Antagonist of the Neuropeptide FF Receptor 1 that Reveals Mechanisms for Subtype Selectivity

Structural basis of antagonist selectivity in endothelin receptors

GABAA receptor subtype selectivity of the proconvulsant rodenticide TETS

Finally an oral V2 selective vasopressin antagonist

Understanding subtype-selective allosteric modulation of GABAAreceptors

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivates

Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

Binding kinetics drive G protein subtype selectivity at the β1-adrenergic receptor

Discovery and molecular basis of subtype-selective cyclophilin inhibitors

Structure‐Based Evolution of Subtype‐Selective Neurotensin Receptor Ligands

Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor

Cell-based monitoring and multiplexing of ERBB receptor activity, antagonist selectivity and pathway responses

Related objects

Reset password